Alto Neuroscience, Inc. (ANRO) — Financial Flexibility Index
Alto Neuroscience, Inc. (ANRO) has a Financial Flexibility Index of -0.34x as of December 2025. Free cash flow of $-11.52 Million (operating CF $-11.52 Million minus capex $0.00) represents 0% of total liabilities ($33.55 Million). Check tangible equity quality of Alto Neuroscience, Inc. to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alto Neuroscience, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Alto Neuroscience, Inc. across 5 annual periods. For the full cash flow conversion analysis, see ANRO cash generation efficiency.
Annual Financial Flexibility Index for Alto Neuroscience, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Alto Neuroscience, Inc.. Explore how well can Alto Neuroscience, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.54x | $-51.74 Million | $-51.77 Million | $33.55 Million | ▲ +11.3% |
| 2024 | -1.74x | $-45.35 Million | $-47.42 Million | $26.08 Million | ▼ -734.6% |
| 2023 | -0.21x | $-32.98 Million | $-33.45 Million | $158.30 Million | ▲ +5.4% |
| 2022 | -0.22x | $-19.66 Million | $-20.39 Million | $89.26 Million | ▼ -5.9% |
| 2021 | -0.21x | $-8.58 Million | $-9.26 Million | $41.27 Million | — |